Marrone Bio Innovations Announces the Availability of Amplitude™ Biofungicide for White Mold Control in the 2018 Growing Se...
December 08 2017 - 8:30AM
Marrone Bio Innovations, Inc. (NASDAQ:MBII) (MBI), a leading
provider of bio-based pest management and plant health products for
agriculture, turf and ornamental and water treatment markets, today
announced the launch and availability of a high-performance and
cost-effective biological fungicide, Amplitude™, in the 2018
growing season. Using the same active ingredient in the recently
EPA approved Stargus™, Amplitude expands the use of this exciting
new product to large acre crops.
Amplitude is based on a new strain of Bacillus
amyloliquefaciens, discovered by MBI, that has shown strong
performance against white molds and soil diseases such as
Phytophthora, Rhizoctonia (pink rot and black scurf of potatoes),
and Fusarium, as shown in field trials in the U.S., Canada and
Europe.
When assessing the market place, MBI has
identified that growers have often struggled to find great
performing products for white mold in those important crops.
They have few choices of products that perform well on the
group of fungi that causes white molds on pulses, dry beans, bulb
vegetables, soybeans, canola and sunflower. Amplitude™, which
addresses this specific market need, is the direct result of MBI’s
directed screening discovery program. This product is also
complementary and additive to the broad spectrum of diseases
covered by MBI’s first biofungicide, Regalia®, providing a solid
one-two punch in controlling white molds and soil diseases. MBI and
partners also are testing this Bacillus-based product for seed
treatment applications.
“We are pleased to provide growers with this
unique tool to control white molds and soil diseases on a broad
range of large acre crops, as well as on pulse, tuber and root
crops. The development of this product is particularly timely in
light of the development of resistance to conventional fungicide
products. Amplitude can be used alone, but can also be combined
with a conventional fungicide for a great ROI,” said André
Trépanier, MBI’s Director of Marketing. “White mold tends to be a
devastating disease in these crops, often causing significant
economic damage if left unchecked.”
Tests conducted at MBI’s research and
development lab show that AmplitudeTM works by colonizing a plant’s
root hairs, stems and other surfaces to prevent establishment of
fungal and bacterial pathogens, including Fusarium, Sclerotinia,
Rhizoctonia, Verticillium, Phytophthora and Sclerotium. Test
results also indicated that the bacterium produces natural
compounds, some of which inhibit bacterial and fungal mycelial
growth, as well as spore germination. In addition, the bacteria
trigger systemic acquired resistance and induced systemic responses
in the plant, creating a healthier and stronger plant to ward off
diseases and promote plant health, growth and increased yield.
MBI has been issued a patent on the novel strain used in
AmplitudeTM.
Extensive field studies with growers have
confirmed and demonstrated excellent efficacy against white mold on
various pulse crops, soybean, sunflower and canola, as well as
Cercospora leaf spot on sugar beets. Testing for soil applications
on potatoes for control of Rhizoctonia (Black scurf) and
Phytophthora eurythroseptica (pink rot) have also delivered
excellent results. Successful field trials have been conducted in
the United States, Mexico, Canada and Europe.
The biofungicide product has also been submitted to Canada and
Mexico for approval and the dossier is being prepared for the
European Union. In the United States, pulse crop and potato acres
affected by white mold increase yearly. In pulse crops like
lentils, the yield loss to white mold can easily reach 50%. Canada
and Europe are expected to grow 9.3 million and 6.7 million
hectares of Canola (oilseed rape) in 2017 respectively1; white mold
is the most serious disease facing these crops.
1 Canola Council of Canada, European Commission
on Agriculture and Rural Development
About Marrone Bio Innovations
Smart. Natural. Solutions.Marrone Bio
Innovations, Inc. (NASDAQ: MBII) strives to lead the movement to a
more sustainable world through the discovery, development and
promotion of biological products for pest management and plant
health. MBI’s effective and environmentally responsible pest
management solutions help customers operate more sustainably while
uniquely improving plant health and increasing crop yields. MBI
currently has seven commercially available products (Regalia®,
Grandevo®, Venerate®, Majestene®, Haven® Stargus™ and Zequanox®) as
well as seven product candidates in various stages of the company’s
rapid development pipeline. MBI also distributes Bio-tam 2.0® for
Isagro USA and Jet-Ag® for Jet Harvest in most regions of the
U.S.
Marrone Bio Innovations is dedicated to pioneering smart
biopesticide solutions that support a better tomorrow for both
farmers and consumers around the globe. For more information,
please visit www.marronebio.com.
Marrone Bio Innovations Forward Looking
StatementsThis press release contains forward-looking
statements that involve substantial risks and uncertainties.
All statements, other than statements of historical facts, included
in this press release regarding strategy, future operations and
plans, including assumptions underlying such statements, are
forward-looking statements, and should not be relied upon as
representing MBI’s views as of any subsequent date. Examples
of such statements include statements regarding the potential of
Amplitude in the market, market projections, including the
potential benefits of Amplitude, and MBI’s plans for expanding
additional label uses and international expansion. Such
forward-looking statements are based on information available to
the Company as of the date of this release and involve a number of
risks and uncertainties, some beyond the Company's control, that
could cause actual results to differ materially from those
anticipated by these forward-looking statements, including
consumer, regulatory and other factors affecting demand for the
MBI’s products, any difficulty in marketing MBI’s products in its
target markets inside and outside the United States, competition in
the market for pest management products, lack of understanding of
bio-based pest management products by customers and growers.
Additional information that could lead to material changes in MBI’s
performance is contained in its filings with the SEC. MBI is
under no obligation to, and expressly disclaims any responsibility
to, update or alter forward-looking statements contained in this
release, whether as a result of current information, future events
or otherwise.
Marrone Bio Innovations Contacts:Pam Marrone,
CEO and FounderAndre Trepanier, Director of MarketingTelephone: +1
(530) 750-2800Email: Info@marronebio.com
MBI Investor Relations:Greg FalesnikManaging
DirectorMZ Group – MZ North AmericaMain: 949-385-6449
MBII@mzgroup.us
www.mzgroup.us
Marrone Bio Innovations (NASDAQ:MBII)
Historical Stock Chart
From Aug 2024 to Sep 2024
Marrone Bio Innovations (NASDAQ:MBII)
Historical Stock Chart
From Sep 2023 to Sep 2024